MDx-Chex® for BC-GP and MDx-Chex® for BC-GN
MDx-Chex for BC-GP and BC-GN are controls designed to evaluate the entire analytical process of the Luminex VERIGENE® BC-GP and BC-GN Panels for sepsis. With MDx-Chex for BC-GP and BC-GN, you can track lot-to-lot performance of the BC-GP and BC-GN assays and reduce the occurrence of incorrect results due to instrument or assay failures.
Product Description
MDx-Chex for BC-GP and BC-GN are patient-like full process controls designed to validate the entire analytical process of the Luminex VERIGENE BC-GP and BC-GN Panels, including automated nucleic acid extraction, DNA purification, hybridization of target DNA to the microarray, hybridization of gold nanoparticles to target DNA and silver staining of hybridized probes. MDx-Chex for BC-GP and BC-GN cover all targets tested with Luminex VERIGENE for BC-GP or BC-GN, respectively. Microorganisms are intact, inactivated and…
Keep sepsis testing on target with MDx-Chex controls
Watch this video to learn how MDx-Chex controls comprehensively evaluate the performance of your BIOFIRE® BCID2 and VERIGENE BC-GP and BC-GN sepsis tests.
Features
- Patient-like matrix of inactivated microorganisms, blood cells and culture media components
- Can be directly used on the Luminex VERIGENE system
- Complete coverage of all BC-GP or BC-GN Panel targets in a single vial
- Negative controls contain only blood cells and culture media components for a true patient-like negative control
Benefits
- Challenges and verifies the entire analytical process of the Luminex VERIGENE assays
- Reduces preanalytical variables such as pipetting errors and cross-contamination
- Easy to use — simply pipette like a patient sample
Benefits of MDx-Chex for BC-GP and BC-GN over other available controls | |||
Streck | Competitor A | Competitor B | |
Preanalytical Variables | |||
Sample tracking (via barcode)^ | Yes | No | No |
Controls technician sample handling | Yes | No | No+ |
Preanalytical Variables | |||
Lysing | |||
Contains non-infectious intact organisms | Yes | No | Yes |
Contains human RBCs and WBCs | Yes | No | No |
Lyses all panel organisms | Yes | No | Yes* |
Nucleic Acid Isolation and Purification | Yes | No | No |
Patient-like sample matrix | Yes | No | No |
Inhibitors | |||
RBCs (i.e., hemoglobin) | Yes | No | No |
WBCs (i.e., interleukin, human genomic DNA) | Yes | No | No |
Culture media chemicals | Yes | No | No |
Specificity | |||
All targets present | Yes | Yes** | Yes* |
Off target (human gDNA) present | Yes | No | No |
Detection | |||
All DNA targets | Yes• | No | Yes* |
FDA Class II Clearance | Yes | No | No |
+ Requires pooling of multiple components, not part of patient sample testing workflow
* If all panel organisms are pooled
• Streck controls contain all DNA targets for the Luminex VERIGENE BC-GP and BC-GN Tests
** When Lyophilized pellets are rehydrated and pooled together
^ Barcode allows the control lot number, expiration date and level to be captured in the software
Ordering Information
Description | Catalog Number |
---|---|
MDx-Chex for BC-GP – 5 Positive control vials & 5 Negative control vials, 5 control events | 250079 |
MDx-Chex for BC-GN – 5 Positive control vials & 5 Negative control vials, 5 control events | 250080 |
Order MDx-Chex for BC-GP and BC-GN today
New customers
Existing customers
International customers find a distributor
Resources
Instructions (IFU)
Assays
Certificates
SDS
Product Information
ESCMID 2024 Presentation:
Molecular diagnostic tests: Why do you QC? Let’s get real…
Looking for an older document? Click here for archived assays and certificates.
Molecular Products
With full-process controls and antibiotic resistance kits, Streck has the products to help you streamline your molecular diagnostics testing, aid antibiotic stewardship and ensure positive patient outcomes.